UOC
RKDA icon

UBS O'Connor’s Arcadia Biosciences RKDA Stock Holding History

UBS O'Connor’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-125
Closed -$278K – 494
2016
Q1 		$278K Sell
125
-38
-23% -$80.7K 0.01% 388
2015
Q4 		$395K Sell
163
-26
-14% -$67.7K 0.01% 367
2015
Q3 		$461K Sell
189
-93
-33% -$387K 0.01% 425
2015
Q2 		$1.44M Buy
+282
New +$1.76M 0.02% 350

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS O'Connor's RKDA Position: Q2 2016 in Review

UBS O'Connor sold out of Arcadia Biosciences (RKDA) in Q2 2016, closing a stake of 125 shares — an estimated $278K sold.

UBS O'Connor first reported a position in RKDA in Q2 2015 and held it in 4 quarters. The position peaked at $1.44M in Q2 2015. 20 funds tracked by Wall St. Rank hold RKDA as of Q2 2016.

  • UBS O'Connor reported no remaining Arcadia Biosciences position as of Q2 2016 after selling out during the quarter.
  • UBS O'Connor sold 125 Arcadia Biosciences shares in Q2 2016, an estimated $278K.
  • UBS O'Connor first reported a position in Arcadia Biosciences in Q2 2015 and held it in 4 quarters.
  • UBS O'Connor's Arcadia Biosciences position peaked at $1.44M in Q2 2015.
  • 20 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2016.

Based on UBS O'Connor's 13F filing for Q2 2016, filed 12 Aug 2016.